Inosine triphosphate pyrophosphatase polymorphisms are predictors of anemia in Chinese patients with chronic hepatitis C during therapy with ribavirin and interferon-Reference-Cited by-同舟云学术

Inosine triphosphate pyrophosphatase polymorphisms are predictors of anemia in Chinese patients with chronic hepatitis C during therapy with ribavirin and interferon

Published:2019-08-23 Issue:1 Volume:35 Page:97-103
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:Journal of Gastroenterology and Hepatology

Author:

Chi Xiumei¹,Wang Moli²,Pan Yu¹,Jiang Jing³,Jiang Tao⁴,Yan Hongqing¹,Wu Ruihong¹,Wang Xiaomei¹,Gao Xiuzhu¹,Niu Junqi¹

Affiliation:

1. Department of HepatologyThe First Hospital of Jilin University Changchun China

2. Department of HepatologyThe Fourth Hospital of Jilin University Changchun China

3. Department of Clinical EpidemiologyThe First Hospital of Jilin University Changchun China

4. Infectious Disease Hospital of Jilin Province Changchun China

Funder

National Natural Science Foundation of China

National Major Science and Technology Projects of China

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jgh.14812

Reference39 articles.

1. Global epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypes

2. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study

3. Epidemiology and management of hepatitis C virus infections in immigrant populations

4. Prevalence of hepatitis C virus infection among key populations in China: A systematic review

5. Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: A 5-year follow-up of 150 patients

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inosine Triphosphate Pyrophosphatase (ITPase): Functions, Mutations, Polymorphisms and Its Impact on Cancer Therapies;Cells;2022-01-24

2. Pharmacogenomic landscape of COVID-19 therapies from Indian population genomes;Pharmacogenomics;2021-07

3. Sofosbuvir‐based therapies in genotype 2 hepatitis C virus cirrhosis: A real‐life experience with focus on ribavirin dose;Pharmacology Research & Perspectives;2021-06-20

4. Papain-Like Proteases as Coronaviral Drug Targets: Current Inhibitors, Opportunities, and Limitations;Pharmaceuticals;2020-09-28